C07C 311/45
At least one of the singly-bound nitrogen atoms being part of any
Official title: at least one of the singly-bound nitrogen atoms being part of any of the groups [IMAGE cpc-sch-C07C-0976.gif], X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
C07C311/45 (At least one of the singly-bound nitrogen atoms being part of any) appears on 531 US grants and 480 published applications in this corpus.
Search patents in C07C- Granted patents
- 531
- Published applications
- 480
- Assignees
- 278
- Inventors
- 1,764
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 17 | 0 |
| 1997 | 17 | 0 |
| 1998 | 25 | 0 |
| 1999 | 19 | 0 |
| 2000 | 16 | 0 |
| 2001 | 22 | 4 |
| 2002 | 34 | 24 |
| 2003 | 30 | 41 |
| 2004 | 16 | 45 |
| 2005 | 25 | 30 |
| 2006 | 14 | 24 |
| 2007 | 21 | 23 |
| 2008 | 20 | 22 |
| 2009 | 22 | 31 |
| 2010 | 13 | 29 |
| 2011 | 16 | 15 |
| 2012 | 21 | 17 |
| 2013 | 18 | 20 |
| 2014 | 18 | 25 |
| 2015 | 18 | 16 |
| 2016 | 11 | 12 |
| 2017 | 14 | 13 |
| 2018 | 8 | 9 |
| 2019 | 11 | 10 |
| 2020 | 9 | 16 |
| 2021 | 10 | 7 |
| 2022 | 5 | 10 |
| 2023 | 5 | 11 |
| 2024 | 6 | 13 |
| 2025 | 5 | 8 |
| 2026 | 8 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- A method of treating seeds and seeds produced thereby13 Aug 2026US 2026/0231848 A1Cyprus University of Technology
- Inhibitors of the ras oncoprotein, methods of making and methods of use thereof13 Aug 2026US 2026/0232689 A1University of Louisville Research Foundation, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Dihydroindene derivatives as malt1 inhibitors2 Jul 2026US 2026/0184687 A1C4X Discovery Limited
- Compounds and methods for treating cancer18 Jun 2026US 2026/0166051 A1The Regents of the University of California
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996